Work

9120 Second-line amrubicin vs topotecan in extensive-disease small cell lung cancer (ED-SCLC) sensitive to first-line platinum-based chemotherapy: updated results of a randomized phase 2 trial

Year: 2009
Type: article
Study design: Clinical Trial
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W2076555367
FWCI:
Cites:
Cited by: 1
Related to: 10